F. Lozano

发表

Outbreak of Brucella melitensis among microbiology laboratory workers

E. Martín-Mazuelos, J. Gómez-Mateos, M. Nogales, 1994, Journal of clinical microbiology.

[Characterising people who demanded the rapid HIV test in Andalusia between 2013 and 2014].

F. Lozano, N. Lorusso, C. Zamora, 2017, Anales del sistema sanitario de Navarra.

Insulin resistance is not associated with liver fibrosis progression in HIV/hepatitis C virus‐coinfected patients

J. Macías, J. Pineda, J. Gómez-Mateos, 2006, Journal of viral hepatitis.

Bacterial Meningitis in HIV-1-Infected Patients in the Era of Highly Active Antiretroviral Therapy

F. Vidal, E. Ribera, J. Cosín, 2009, Journal of acquired immune deficiency syndromes.

Gynaecomastia in HIV-Infected Men on Highly Active Antiretroviral Therapy: Association with Efavirenz and Didanosine Treatment

J. Macías, J. Pineda, A. Fernández-Palacín, 2004, Antiviral therapy.

Low-level liver enzyme elevations during HAART are not associated with liver fibrosis progression among HIV/HCV-coinfected patients.

J. Macías, J. Pineda, J. Gómez-Mateos, 2006, The Journal of antimicrobial chemotherapy.

Characteristics and outcome of HIV infection in gypsies in the Spanish VACH Cohort.

F. Vidal, E. Ribera, J. Cosín, 2010, Enfermedades infecciosas y microbiologia clinica.

Efavirenz trough levels are not associated with virological failure throughout therapy with 800 mg daily and a rifampicin-containing antituberculosis regimen.

L. López-Cortés, F. Lozano, A. Marín-Niebla, 2006, The Journal of antimicrobial chemotherapy.

First-line antiretroviral therapy with efavirenz or lopinavir/ritonavir plus two nucleoside analogues: the SUSKA study, a non-randomized comparison from the VACH cohort.

F. Vidal, E. Ribera, J. Cosín, 2008, The Journal of antimicrobial chemotherapy.

Prospective evaluation of fever of unknown origin in patients infected with the human immunodeficiency virus

J. Torre-Cisneros, A. Vergara, P. Viciana, 1996, European Journal of Clinical Microbiology and Infectious Diseases.

Simplicity and Efficacy of a Once-Daily Antiretroviral Regimen with Didanosine, Lamivudine, and Efavirenz in Naïve Patients: The VESD Study

J. De La Torre, A. Rivero, L. López-Cortés, 2005, HIV clinical trials.

Dyslipidaemia in HIV-infected women on antiretroviral therapy. Analysis of 922 patients from the Spanish VACH cohort

J. Cosín, M. Fuentes-Ferrer, P. Viciana, 2011, BMC women's health.

Clinical and Virological Efficacy of Etravirine Plus Two Active Nucleos(t)ide Analogs in an Heterogeneous HIV-Infected Population

P. Viciana, L. López-Cortés, F. Lozano, 2014, PloS one.

Liver toxicity of antiretroviral combinations including atazanavir/ritonavir in patients co-infected with HIV and hepatitis viruses: impact of pre-existing liver fibrosis.

J. Macías, J. Pineda, Á. Camacho, 2008, The Journal of antimicrobial chemotherapy.

Hepatitis C virus and human immunodeficiency virus coinfection in Spain.

E. Ribera, J. Cosín, P. Viciana, 2003, The Journal of infection.

Tuberculous splenic abscesses in patients with the acquired immune deficiency syndrome.

F. García‐Bragado, L. López-Cortés, J. Gómez-Mateos, 1991, Tubercle.

Disorders of body fat distribution in HIV-1-infected patients.

E. Negredo, E. Martinez, S. Moreno, 2009, AIDS reviews.

[Recommendations of the Study Group for Metabolic Alterations/Secretariat for the National AIDS Plan (GEAM/SPNS) on the management of metabolic and morphologic alterations in patients with HIV infection].

E. Martinez, S. Johnston, F. Pulido, 2006, Enfermedades infecciosas y microbiologia clinica.

Increased hepatocyte fas expression and apoptosis in HIV and hepatitis C virus coinfection.

J. Macías, J. Pineda, C. Sáez, 2005, The Journal of infectious diseases.

Analysis of the costs and cost-effectiveness of the guidelines recommended by the 2018 GESIDA/Spanish National AIDS Plan for initial antiretroviral therapy in HIV-infected adults.

E. Negredo, J. Miro, J. Gatell, 2019, Enfermedades infecciosas y microbiologia clinica.

High quality of life, treatment tolerability, safety and efficacy in HIV patients switching from triple therapy to lopinavir/ritonavir monotherapy: A randomized clinical trial

C. Hidalgo-Tenorio, M. Fariñas, F. Lozano, 2018, PloS one.

Correlation of Fluconazole MICs with Clinical Outcome in Cryptococcal Infection

A. Espinel-Ingroff, L. Steele-Moore, A. Aller, 2000, Antimicrobial Agents and Chemotherapy.

The relationship between antiretroviral prescription patterns and treatment guidelines in treatment‐naïve HIV‐1‐infected patients

E. Ribera, J. Cosín, P. Viciana, 2009, HIV medicine.

Real world effectiveness of standard of care triple therapy versus two-drug combinations for treatment of people living with HIV

S. Marguet, E. Ribera, J. Peraire, 2021, PloS one.

Survival and prognostic factors of HIV-infected patients with HCV-related end-stage liver disease

J. Torre-Cisneros, J. Macías, J. Pineda, 2006, AIDS.

Effectiveness and safety of didanosine, lamivudine and efavirenz versus zidovudine, lamivudine and efavirenz for the initial treatment of HIV-infected patients from the Spanish VACH cohort.

F. Vidal, E. Ribera, M. Crespo, 2008, The Journal of antimicrobial chemotherapy.

Effect of antiretroviral drugs on liver fibrosis in HIV-infected patients with chronic hepatitis C: harmful impact of nevirapine

J. Macías, J. Pineda, C. Sáez, 2004, AIDS.

[Randomized trial of three regimens to prevent tuberculosis in HIV-infected patients with anergy].

A. Rivero, F. Lozano, J. Pasquau, 2003, Enfermedades infecciosas y microbiologia clinica.

Cervical lipomatosis in HIV‐infected patients: a case–control study

A. Del Arco, A. Rivero, F. Lozano, 2007, HIV medicine.

Dynamics of creatinine estimated glomerular filtration rate using one or more antiretrovirals that inhibit creatinine tubular secretion.

E. Negredo, E. Martinez, J. De La Torre, 2021, The Journal of antimicrobial chemotherapy.

Low incidence of acute hepatitis C virus infection among Southern Spanish HIV-infected individuals.

L. Real, J. Macías, J. Pineda, 2017, The Journal of infection.

[Management of antiretroviral drug toxicity].

F. Lozano, P. Domingo, 2011, Enfermedades infecciosas y microbiologia clinica.

Long-term assessment of didanosine, lamivudine, and efavirenz in antiretroviral-naive patients: 3-year follow-up.

A. Rivero, L. López-Cortés, F. Lozano, 2008, AIDS research and human retroviruses.

Massive hemoperitoneum: a new manifestation of bacillary peliosis in human immunodeficiency virus infection.

C. Rufo, J. Gómez-Mateos, F. Lozano, 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

SARS-CoV-2 infection in patients with primary central nervous system lymphoma

K. Hoang-Xuan, A. Idbaih, N. Martin-Duverneuil, 2021, Journal of Neurology.

Costs and cost-efficacy analysis of the 2017 GESIDA/Spanish National AIDS Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adults.

J. Gatell, E. Martinez, J. De La Torre, 2018, Enfermedades infecciosas y microbiologia clinica.

Costs and cost-efficacy analysis of the 2016 GESIDA/Spanish AIDS National Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adults.

J. Gatell, J. De La Torre, M. Crespo, 2017, Enfermedades infecciosas y microbiologia clinica.

Costs and cost-effectiveness analysis of 2015 GESIDA/Spanish AIDS National Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adults.

D. Podzamczer, B. Clotet, J. Miro, 2017, Enfermedades infecciosas y microbiologia clinica.

National Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adults

D. Podzamczer, B. Clotet, J. Miro, 2016 .

D. Podzamczer, J. Gatell, A. Rivero, 2015 .

[Costs and cost-efficacy analysis of the preferred treatments by GESIDA/National Plan for AIDS for the initial antiretroviral therapy in adult human immunodeficiency virus (HIV) infected patients in 2012].

D. Podzamczer, B. Clotet, J. Miro, 2012, Enfermedades infecciosas y microbiologia clinica.

Etiology of spontaneous pneumothorax in 105 HIV-infected patients without highly active antiretroviral therapy.

E. Cordero, J. Torre-Cisneros, Á. Camacho, 2009, European journal of radiology.

Prevention and treatment of opportunistic infections and other coinfections in HIV-infected patients: May 2015.

D. Podzamczer, J. Mallolas, J. Caylà, 2016, Enfermedades infecciosas y microbiologia clinica.

Consensus document on the management of renal disease in HIV-infected patients.

E. Negredo, J. Miro, E. Martinez, 2014, Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia.

Catheter associated infection by Bacillus macerans in a patient with acute leukemia

J. Gómez-Mateos, F. Lozano, J. Corzo, 1996 .

Relapsing blepharitis in patients under highly active antiretroviral therapy including indinavir.

J. Gómez-Mateos, F. Lozano, J. A. Mira, 2004, AIDS.

TITLE: FIELD EXPERIENCES WITH INFECTIOUS LARYNGOTRACHEITIS IN PERU AND THE USE OF A LARYNGOTRACHEITIS VECTORED VACCINE.

F. Lozano, M. Cisneros, C. Vinueza, 2008 .

Executive summary: Prevention and treatment of opportunistic infections and other coinfections in HIV-infected patients: May 2015.

D. Podzamczer, J. Mallolas, J. Caylà, 2016, Enfermedades infecciosas y microbiologia clinica.

Stepped-Dose Versus Full-Dose Efavirenz for HIV Infection and Neuropsychiatric Adverse Events

A. Rivero, P. Viciana, F. Lozano, 2009, Annals of Internal Medicine.

Analysis of the costs and cost-effectiveness of the guidelines recommended by the 2018 GESIDA/Spanish National AIDS Plan for initial antiretroviral therapy in HIV-infected adults

E. Negredo, J. Miro, E. Martinez, 2019, Enfermedades infecciosas y microbiologia clinica (English ed.).

Low Incidence of Severe Liver Events in HIV Patients With and Without Hepatitis C or B Coinfection Receiving Lopinavir/Ritonavir

J. Torre-Cisneros, J. Macías, J. Pineda, 2006, HIV clinical trials.

A case-control study of HIV patients with the K65R mutation in the reverse transcriptase gene with virological failure.

A. Rivero, M. Nogales, F. Lozano, 2005, AIDS.

Recommendations from SPNS/GEAM/SENBA/SENPE/AEDN/SEDCA/GESIDA on nutrition in the HIV-infected patient.

J. R. Martínez-Álvarez, I. Jiménez-Nácher, F. Lozano, 2007, Nutricion hospitalaria.

Clinical implications of fixed-dose coformulations of antiretrovirals on the outcome of HIV-1 therapy

B. Clotet, J. Arribas, A. Rivero, 2011, AIDS.

Predictors of Severe Haematological Toxicity Secondary to Pegylated Interferon plus Ribavirin Treatment in HIV-HCV-Coinfected Patients

J. Macías, J. Pineda, A. Rivero, 2007, Antiviral therapy.

Efficacy, safety and pharmacokinetic of once-daily boosted saquinavir (1500/100 mg) together with 2 nucleos(t)ide reverse transcriptase inhibitors in real life: a multicentre prospective study

A. Rivero, P. Viciana, L. López-Cortés, 2010, AIDS research and therapy.

Very low level viraemia and risk of virological failure in treated HIV‐1‐infected patients

E. Ribera, P. Viciana, P. Geijo, 2017, HIV medicine.

[Antiretroviral therapy for HIV infection].

F. Lozano, P. Domingo, 2011, Enfermedades infecciosas y microbiologia clinica.

High lifetime risk of cardiovascular disease vs low 10-year Framingham risk score in HIV-infected subjects under ART in Spain: the Coronator study

J. Olalla, F. Lozano, P. Domingo, 2012, Journal of the International AIDS Society.

International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK

Raúl Tabarés Gutiérrez, Samit R. Joshi, H. Jessen, 2016, Journal of the International AIDS Society.

[Role of fixed-dose combinations of antiretrovirals in HIV-1 therapy].

B. Clotet, J. Gatell, J. Arribas, 2010, Enfermedades infecciosas y microbiologia clinica.

Impaired Recovery of CD4+ Cell Counts Following Highly Active Antiretroviral Therapy in Drug-Naïve Patients Coinfected with Human Immunodeficiency Virus and Hepatitis C Virus

J. Macías, J. Gómez-Mateos, F. Lozano, 2003, European Journal of Clinical Microbiology and Infectious Diseases.

Executive summary of the GeSIDA/National AIDS Plan consensus document on antiretroviral therapy in adults infected by the human immunodeficiency virus (updated January 2014).

D. Podzamczer, B. Clotet, J. Gatell, 2014, Enfermedades infecciosas y microbiologia clinica.

International Congress of Drug Therapy in HIV Infection 2‐6 November 2014, Glasgow, UK

Samit R. Joshi, Charlene A Flash, Thomas Lengauer, 2014 .

Cardiovascular risk factors and lifetime risk estimation in HIV-infected patients under antiretroviral treatment in Spain

J. Olalla, F. Lozano, Jesús Santos, 2015, HIV clinical trials.

Factors associated with the number of drugs in darunavir/cobicistat regimens.

E. Negredo, E. Ribera, M. Pérez-Elías, 2019, The Journal of antimicrobial chemotherapy.

Effectiveness and safety of dual therapy with rilpivirine and boosted darunavir in treatment-experienced patients with advanced HIV infection: a preliminary 24 week analysis (RIDAR study)

J. De La Torre, C. Hidalgo-Tenorio, P. Arazo, 2019, BMC Infectious Diseases.

Relationship Between Low Bone Mineral Density and Highly Active Antiretroviral Therapy Including Protease Inhibitors in HIV-Infected Patients

J. Macías, J. Gómez-Mateos, F. Lozano, 2003, HIV clinical trials.

[Activity of Ertapenem and Ceftriaxone in the eradication of Salmonella in a model of experimental peritonitis in mice].

F. Lozano, J. E. García, M. García, 2009, Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia.

[Leukocytoclastic vasculitis: analysis of 62 cases].

C. Luaces, F. Lozano, F. Cardellach, 1987, Medicina clinica.

Outcomes in HIV-infected patients admitted due to pandemic influenza.

F. Lozano, Jesús Santos, H. Knobel, 2012, Enfermedades infecciosas y microbiologia clinica.

Epilepsy−associated risk factors in patients with brain tumors in a Mexican Hospital

Medina, F. Lozano, Bárcena, 2019 .

Executive summary of the GESIDA/National AIDS Plan Consensus Document on antiretroviral therapy in adults infected by the human immunodeficiency virus (updated January 2015).

D. Podzamczer, B. Clotet, J. Gatell, 2015, Enfermedades Infecciosas y Microbiologia Clinica.

Effectiveness and safety of simplification from tenofovir-lamivudine (TDF-3TC) to tenofovir-emtricitabine (TDF-FTC) co-formulation (Truvada®) in virologically suppressed HIV-infected patients on HAART

A. Rivero, F. Lozano, R. Palacios, 2009, European Journal of Clinical Microbiology & Infectious Diseases.

Impact of Highly Active Antiretroviral Therapy on Fever of Unknown Origin in HIV-Infected Patients

J. Torre-Cisneros, F. Lozano, A. Terrón, 2002, European Journal of Clinical Microbiology and Infectious Diseases.

Outcomes by sex following treatment initiation with darunavir/cobicistat in a large Spanish cohort of the CODAR study (GeSIDA 9316).

J. M. García de Lomas, J. De La Torre, E. Ribera, 2019, The Journal of antimicrobial chemotherapy.

[Decrease in the annual frequency of infectious endocarditis among intravenous drug users in southern Spain].

A. Rivero, A. de Alarcón, A. Vergara, 2000, Enfermedades Infecciosas y Microbiologia Clinica.

Costs and cost-efficacy analysis of the 2014 GESIDA/Spanish National AIDS Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adults.

D. Podzamczer, J. Gatell, A. Rivero, 2015, Enfermedades infecciosas y microbiologia clinica.

Executive summary of the consensus document on osteoporosis in HIV-infected individuals.

E. Negredo, E. Martinez, F. Lozano, 2017, Enfermedades infecciosas y microbiologia clinica.

Fulminant Septic Shock in AIDS Patients Caused by Disseminated Cryptococcosis

J. Gómez-Mateos, F. Lozano, J. Irles, 1999, European Journal of Clinical Microbiology and Infectious Diseases.

Epidemiological trends of HIV infection in Spain: preventative plans have to be oriented to new target populations (Spanish VACH Cohort).

E. Ribera, J. Arribas, J. Cosín, 2002, AIDS.

Lipid Changes in Virologically Suppressed HIV-Infected Patients Switching from any Antiretroviral Therapy to the Emtricitabine/Rilpivirine/Tenofovir Single Tablet

A. Rivero, F. Lozano, Jesús Santos, 2016, Journal of the International Association of Providers of AIDS Care.

Prevalence of non-significant liver fibrosis and rate of fibrosis progression in HIV/hepatitis C virus- co-infected patients: still a role for liver biopsy?

J. Macías, J. Pineda, F. Lozano, 2004, AIDS.

[Bacteremia caused by Enterococcus avium secondary to thrombosis of the lateral sinus and the internal jugular vein].

J. Gómez-Mateos, C. Flórez, F. Lozano, 1996, Enfermedades infecciosas y microbiologia clinica.

Low incidence of severe liver toxicity in patients receiving antiretroviral combinations including atazanavir.

J. Torre-Cisneros, J. Pineda, A. Rivero, 2006, The Journal of antimicrobial chemotherapy.

[Campylobacter bacteremia and HIV infection].

F. Lozano, J. Corzo, M. Pérez, 1992, Enfermedades infecciosas y microbiologia clinica.

Effectiveness and safety of didanosine, lamivudine and efavirenz versus zidovudine, lamivudine and efavirenz for the initial treatment of HIV-infected patients from the Spanish VACH cohort.

F. Vidal, E. Ribera, M. Crespo, 2008, The Journal of antimicrobial chemotherapy.

[Randomized clinical trial investigating three chemoprophylaxis regimens for latent tuberculosis infection in HIV-infected patients].

A. Rivero, F. Lozano, M. Márquez, 2007, Enfermedades infecciosas y microbiologia clinica.

Executive summary of the GeSIDA/National AIDS Plan consensus document on antiretroviral therapy in adults infected by the human immunodeficiency virus (updated January 2018).

D. Podzamczer, E. Negredo, J. Miro, 2019, Enfermedades infecciosas y microbiologia clinica.

[Consensus statement on metabolic disorders and cardiovascular risks in patients with human immunodeficiency virus].

E. Negredo, F. Lozano, R. Palacios, 2015, Enfermedades infecciosas y microbiologia clinica.